Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer: early late toxicity and 3-year clinical outcome.
暂无分享,去创建一个
W. De Neve | N. Lumen | K. Decaestecker | V. Fonteyne | G. De Meerleer | G. Villeirs | P. Ost | K. Vandecasteele | C. Van Praet | Werner De Gersem Ir